Interesting Engineering on MSN
Scientists 3D print muscle tissue in zero gravity to study diseases beyond Earth
ETH Zurich scientists 3D print muscle tissue in simulated zero gravity, paving the way for growing human tissue in space.
This year’s doses protect against three strains of influenza, including two types of influenza A and one type of influenza B.
If cancer is a disease of overabundance, where cells divide without restraint and tumors grow despite the body's best interests, then degenerative diseases are disorders of deprivation. When ...
Takeda (TSE:4502/NYSE:TAK) today announced that the recently FDA-approved HyHub and HyHub Duo devices are now available in the U.S. for patients 17 years of age and older, as prescribed, who are ...
Takeda (TSE:4502/NYSE:TAK) today announced that the recently FDA-approved HyHub and HyHub Duo devices are now available in the U.S. for patients 17 years of age and older, as prescribed, who are ...
TB-500 (a fragment of Thymosin Beta-4) and BPC-157 (Body Protection Compound) are two naturally derived peptide chains that have been the subject of significant academic interest. Each has been ...
Johnson & Johnson today announced plans to initiate the first head-to-head study comparing FcRn blockers for patients with generalized myasthenia gravis (gMG), which aims to affirm IMAAVYtm ...
Dr. Peter Attia has declared war on what he calls the marginal decade, the final years of life that are often plagued by ...
2don MSN
To Save His Hairline, One Man Tried Every Hair-Loss Treatment Going – Here's What Actually Works
From fish DNA injections and PRP to LED helmets and supplements, one man tests every major hair-loss treatment on the market to see what really delivers results.
Tech Xplore on MSN
Artificial muscles use ultrasound-activated microbubbles to move
Researchers at ETH Zurich have developed artificial muscles that contain microbubbles and can be controlled with ultrasound.
If you want to avoid hitting the wall, take a look at your nutrition, training, and race plan.
BridgeBio Pharma Inc.’s drug to treat a devastating muscle-wasting disorder met its goal in a late-stage trial, paving the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results